Showing results (441-450 of 5,265) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|March 11, 2010
Vitamin D deficiency does not alter biochemical markers of bone metabolism before or after autograft in patients with multiple myelomaMichel Laroche, Olivia Lemaire, Michel Attal
European Journal of Haematology|March 3, 2010
The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cellsHomare Eda, Katsuhiko Aoki, Soki Kato, et al.
European Journal of Haematology|June 16, 2017
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AMLMario Tiribelli, Antonella Geromin, Margherita Cavallin, et al.
European Journal of Haematology|June 16, 2017
Detection of iron restriction in anaemic and non-anaemic patients: New diagnostic approachesLothar Thomas, Christian Thomas
European Journal of Haematology|April 28, 2017
Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up dataMarc Poch Martell, Nada Hamad, Elizabeth Shin, et al.
European Journal of Haematology|April 5, 2018
Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer-associated venous thromboembolismBenjamin Simmons, Waldemar Wysokinski, Rayya A Saadiq, et al.
European Journal of Haematology|April 13, 2018
Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individualsDimitra Zacharaki, Roshanak Ghazanfari, Hongzhe Li, et al.
European Journal of Haematology|October 1, 1993
Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsiesP D Jensen, J P Bagger, F T Jensen, et al.
European Journal of Haematology|October 1, 1993
Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562P Tosi, G Visani, E Ottaviani, et al.
Pageof 527